l-carnitine chemotherapy in the Treatment of Psychiatric and Neurological Manifestations: A Systematic Review IV THERAPY - VIT -
Description
Ellis SD, Kelly ST, Shurlock JH, Hepburn ALN
Stability and Applicability It is resistant to moisture degradation and is suitable for solid dosage forms such as tablets and capsules, extending shelf life and improving bioavailability
10.1016/s0006-291x00883-5 Biochem Biophys Res Commun
L-Carnitine: 500-2000 mg/day)
DMB treatment significantly lowers plasma TMAO levels and prevents cardiac dysfunction (Wang et al., 2015), without affecting body weight and dyslipidemia (Konop et al., 2018)
However, these abnormal heart sounds may come and go
